{
  "schema": "picoportal.search-run-provenance/1",
  "exportedAt": "2026-10-29T13:20:35.544Z",
  "tool": {
    "name": "PICO search builder",
    "database": "PubMed via NCBI E-utilities",
    "vocabulary": "NLM MeSH via id.nlm.nih.gov"
  },
  "aiUse": {
    "modelsServed": [],
    "statement": "No generative AI model was used: the strategy was supplied by the searcher and checked with the PICO search builder. Every MeSH heading, Supplementary Concept and publication type was looked up in NLM MeSH (id.nlm.nih.gov): 2 valid. Every line was run in PubMed through NCBI E-utilities on October 28, 2026, and its count compared with the count written in the strategy."
  },
  "run": {
    "id": "35a967e4-efdc-445d-96ba-570527a5f300",
    "kind": "validate",
    "status": "done",
    "stage": "saving",
    "question": null,
    "input": {
      "text": "1. \"Diabetes Mellitus, Type 2\"[Mesh]\n2. \"Glucagon-Like Peptide-1 Receptor Agonists\"[Mesh] OR semaglutide[tiab]\n3. #1 AND #2"
    },
    "strategy": null,
    "lines": [
      {
        "no": 1,
        "kind": "raw",
        "refs": [],
        "count": 204451,
        "query": "\"Diabetes Mellitus, Type 2\"[Mesh]",
        "issues": [],
        "display": "\"Diabetes Mellitus, Type 2\"[Mesh]",
        "countedAt": "2026-10-28T18:00:07.299Z",
        "vocabulary": [
          {
            "tag": "Mesh",
            "kind": "descriptor",
            "label": "Diabetes Mellitus, Type 2",
            "quoted": true,
            "validation": {
              "ui": "D003924",
              "label": "Diabetes Mellitus, Type 2",
              "status": "valid"
            }
          }
        ],
        "diagnostics": {
          "fieldsNotFound": [],
          "outputMessages": [],
          "phrasesIgnored": [],
          "translationSet": [],
          "phrasesNotFound": [],
          "queryTranslation": "\"diabetes mellitus, type 2\"[MeSH Terms]",
          "quotedPhrasesNotFound": []
        },
        "reportedCount": null
      },
      {
        "no": 2,
        "kind": "raw",
        "refs": [],
        "count": 10378,
        "query": "\"Glucagon-Like Peptide-1 Receptor Agonists\"[Mesh] OR semaglutide[tiab]",
        "issues": [],
        "display": "\"Glucagon-Like Peptide-1 Receptor Agonists\"[Mesh] OR semaglutide[tiab]",
        "countedAt": "2026-10-28T20:14:57.582Z",
        "vocabulary": [
          {
            "tag": "Mesh",
            "kind": "descriptor",
            "label": "Glucagon-Like Peptide-1 Receptor Agonists",
            "quoted": true,
            "validation": {
              "ui": "D000097789",
              "label": "Glucagon-Like Peptide-1 Receptor Agonists",
              "status": "valid"
            }
          }
        ],
        "diagnostics": {
          "fieldsNotFound": [],
          "outputMessages": [],
          "phrasesIgnored": [],
          "translationSet": [],
          "phrasesNotFound": [],
          "queryTranslation": "\"Glucagon-Like Peptide-1 Receptor Agonists\"[MeSH Terms] OR \"semaglutide\"[Title/Abstract]",
          "quotedPhrasesNotFound": []
        },
        "reportedCount": null
      },
      {
        "no": 3,
        "kind": "raw",
        "refs": [
          1,
          2
        ],
        "count": 4461,
        "query": "(\"Diabetes Mellitus, Type 2\"[Mesh]) AND (\"Glucagon-Like Peptide-1 Receptor Agonists\"[Mesh] OR semaglutide[tiab])",
        "issues": [],
        "display": "#1 AND #2",
        "countedAt": "2026-10-28T20:14:57.338Z",
        "diagnostics": {
          "fieldsNotFound": [],
          "outputMessages": [],
          "phrasesIgnored": [],
          "translationSet": [],
          "phrasesNotFound": [],
          "queryTranslation": "\"diabetes mellitus, type 2\"[MeSH Terms] AND (\"Glucagon-Like Peptide-1 Receptor Agonists\"[MeSH Terms] OR \"semaglutide\"[Title/Abstract])",
          "quotedPhrasesNotFound": []
        },
        "reportedCount": null
      }
    ],
    "finalQuery": "(\"Diabetes Mellitus, Type 2\"[Mesh]) AND (\"Glucagon-Like Peptide-1 Receptor Agonists\"[Mesh] OR semaglutide[tiab])",
    "finalCount": 4461,
    "issues": [],
    "recall": null,
    "seeds": null,
    "reference": null,
    "records": [
      {
        "pmid": "42947001",
        "year": "2026",
        "title": "Comparison of cardiac adverse event signal profiles for GLP-1 receptor agonists: an analysis of the FAERS database.",
        "authors": "Yildirim BO, Sarkim IF, Yalman G et al.",
        "journal": "BMC cardiovascular disorders",
        "publicationTypes": [
          "Journal Article",
          "Comparative Study"
        ]
      },
      {
        "pmid": "42946127",
        "year": "2026",
        "title": "Semaglutide and Panic Attacks: Active-Comparator Disproportionality Analysis, Temporal Assessment of Notoriety Bias and Evidence Triangulation in Post-Marketing Pharmacovigilance.",
        "authors": "Melamed B, Parsi-Zahabi M, Omrani MA et al.",
        "journal": "Pharmacoepidemiology and drug safety",
        "publicationTypes": [
          "Journal Article"
        ]
      },
      {
        "pmid": "42944687",
        "year": "2026",
        "title": "GLP-1 RA Prescribing in Patients With Type 2 Diabetes and Cancer.",
        "authors": "Hu X, Jiang C, Han X et al.",
        "journal": "JAMA network open",
        "publicationTypes": [
          "Journal Article"
        ]
      },
      {
        "pmid": "42944684",
        "year": "2026",
        "title": "Prescribing SGLTis and GLP-1 RAs for Patients With Type 2 Diabetes, Guideline Updates, and Longitudinal Knowledge Assessment Scores.",
        "authors": "Gray BM, Vandergrift J, Landon BE et al.",
        "journal": "JAMA network open",
        "publicationTypes": [
          "Journal Article"
        ]
      },
      {
        "pmid": "42942883",
        "year": "2026",
        "title": "Impact of GLP-1 Receptor Agonists on Cognitive Performance in Adults at Risk of Alzheimer's Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.",
        "authors": "Abbatecola AM, Migliara G, D'Agostino F et al.",
        "journal": "Nutrients",
        "publicationTypes": [
          "Journal Article",
          "Systematic Review",
          "Meta-Analysis",
          "Review"
        ]
      },
      {
        "pmid": "42942021",
        "year": "2026",
        "title": "GLP-1 Receptor Agonist Therapy in Patients with Cancer: A Review of Clinical Outcomes.",
        "authors": "Andronescu AC, Ciumărnean L, Orășan OH et al.",
        "journal": "International journal of molecular sciences",
        "publicationTypes": [
          "Journal Article",
          "Systematic Review",
          "Review"
        ]
      },
      {
        "pmid": "42941904",
        "year": "2026",
        "title": "Association of Glucagon-like Peptide-1 Receptor Agonists Versus Dipeptidyl Peptidase-4 Inhibitors with Tuberculosis and Mortality in Adults with Diabetes.",
        "authors": "Hsu CH, Chang R, Chen CF et al.",
        "journal": "International journal of molecular sciences",
        "publicationTypes": [
          "Journal Article",
          "Observational Study"
        ]
      },
      {
        "pmid": "42937793",
        "year": "2026",
        "title": "Efficacy and safety of GLP-1 receptor agonists in patients with metabolic dysfunction-associated steatotic liver disease (MASLD) and metabolic dysfunction-associated steatohepatitis (MASH): A systematic review and meta-analysis.",
        "authors": "Alfawaz M, Bajamaan D, Alghamdi L et al.",
        "journal": "Medicine",
        "publicationTypes": [
          "Journal Article",
          "Systematic Review",
          "Meta-Analysis"
        ]
      },
      {
        "pmid": "42918905",
        "year": "2026",
        "title": "GLP-1-based therapies in cardiovascular disease: outcomes, mechanisms, and emerging clinical applications.",
        "authors": "Jang R, Jang M, Ruan X et al.",
        "journal": "European journal of clinical pharmacology",
        "publicationTypes": [
          "Journal Article",
          "Review"
        ]
      },
      {
        "pmid": "42916694",
        "year": "2026",
        "title": "Oral Small-Molecule GLP-1 Receptor Agonists: Lessons from Clinical Candidates and a Blueprint for Next-Generation Design.",
        "authors": "Hu J, Zhang Y, Wang M et al.",
        "journal": "Journal of medicinal chemistry",
        "publicationTypes": [
          "Journal Article"
        ]
      },
      {
        "pmid": "42910111",
        "year": "2026",
        "title": "Association of GLP-1 Receptor Agonist Use with Thyroid Outcomes in Adults with Type 2 Diabetes.",
        "authors": "Hsiao CC, Tsai MH, Jhu JY et al.",
        "journal": "International journal of medical sciences",
        "publicationTypes": [
          "Journal Article"
        ]
      },
      {
        "pmid": "42905300",
        "year": "2026",
        "title": "Decoding the Safety Profile of GLP-1 Receptor Agonists: Facts, Myths, and Ongoing Controversies.",
        "authors": "Kounatidis DC, Vallianou NG, Kouveletsou M et al.",
        "journal": "Current obesity reports",
        "publicationTypes": [
          "Journal Article",
          "Review"
        ]
      },
      {
        "pmid": "42902671",
        "year": "2026",
        "title": "Real-world Challenges and Predictors of Success in Glucagon-like Peptide-1 Receptor Agonist Therapy.",
        "authors": "Patankar NM, Sanghvi SJ",
        "journal": "The Journal of the Association of Physicians of India",
        "publicationTypes": [
          "Journal Article",
          "Review"
        ]
      },
      {
        "pmid": "42899606",
        "year": "2026",
        "title": "Effectiveness of Weekly Semaglutide Treatment (0.5 or 1 mg) in Chilean Patients with Type 2 Diabetes Mellitus.",
        "authors": "Estica M, Godoy G, Vargas C et al.",
        "journal": "Revista medica de Chile",
        "publicationTypes": [
          "Journal Article",
          "Multicenter Study",
          "Clinical Trial, Phase IV"
        ]
      },
      {
        "pmid": "42898660",
        "year": "2026",
        "title": "Glucagon-like peptide-1 receptor agonists and aesthetic surgery: perioperative safety, timing, durability and body composition.",
        "authors": "Chaturvedi R, Singh K, Chakole RR et al.",
        "journal": "Frontiers in endocrinology",
        "publicationTypes": [
          "Journal Article",
          "Review"
        ]
      },
      {
        "pmid": "42890523",
        "year": "2026",
        "title": "CagriSema versus Semaglutide 2.4 mg monotherapy for weight management in adults with overweight or obesity, with or without type 2 diabetes: a systematic review, meta-analysis, and trial sequential analysis.",
        "authors": "Rasool ZK, Shah R, Batool AEZ et al.",
        "journal": "Frontiers in endocrinology",
        "publicationTypes": [
          "Journal Article",
          "Systematic Review",
          "Meta-Analysis"
        ]
      },
      {
        "pmid": "42886550",
        "year": "2026",
        "title": "Pharmacy students' knowledge and attitudes regarding GLP-1 receptor agonist adverse effects in obesity management: a cross-sectional study.",
        "authors": "Khojah AA, Gazzaz MJ, Aldurdunji MM et al.",
        "journal": "The Libyan journal of medicine",
        "publicationTypes": [
          "Journal Article"
        ]
      },
      {
        "pmid": "42885796",
        "year": "2026",
        "title": "Glucagon-Like Peptide-1 Receptor Agonists and Incident Cardiovascular Events and Death in Treated Serious Mental Illness, Type 2 Diabetes, and Obesity.",
        "authors": "Governor SB, Dávila-García DM, Rivera-Segarra E et al.",
        "journal": "Journal of the American Heart Association",
        "publicationTypes": [
          "Journal Article"
        ]
      },
      {
        "pmid": "42874603",
        "year": "2026",
        "title": "GLP-1 receptor agonist initiation and risk of psychiatric hospitalisation and emergency department presentation in adults with schizophrenia and type 2 diabetes in the USA: an observational cohort study using electronic health records data.",
        "authors": "Davoodian N, Williams LJ, Berk M et al.",
        "journal": "The lancet. Psychiatry",
        "publicationTypes": [
          "Journal Article",
          "Observational Study"
        ]
      },
      {
        "pmid": "42866418",
        "year": "2026",
        "title": "Values, preferences, and treatment burden for initiation of GLP-1 receptor agonists, SGLT-2 inhibitors, tirzepatide, and finerenone in adults with type 2 diabetes: systematic review.",
        "authors": "González-Cruz DC, Garcia-Campa M, Moreno-Peña PJ et al.",
        "journal": "BMJ medicine",
        "publicationTypes": [
          "Journal Article",
          "Systematic Review"
        ]
      }
    ],
    "error": null,
    "createdAt": "2026-10-28T20:14:56.344Z",
    "finishedAt": "2026-10-28T20:15:00.795Z",
    "versionNo": 1
  },
  "versions": [
    {
      "versionNo": 1,
      "createdBy": "import",
      "strategy": null,
      "lines": [
        {
          "no": 1,
          "kind": "raw",
          "refs": [],
          "count": 204451,
          "query": "\"Diabetes Mellitus, Type 2\"[Mesh]",
          "issues": [],
          "display": "\"Diabetes Mellitus, Type 2\"[Mesh]",
          "countedAt": "2026-10-28T18:00:07.299Z",
          "vocabulary": [
            {
              "tag": "Mesh",
              "kind": "descriptor",
              "label": "Diabetes Mellitus, Type 2",
              "quoted": true,
              "validation": {
                "ui": "D003924",
                "label": "Diabetes Mellitus, Type 2",
                "status": "valid"
              }
            }
          ],
          "diagnostics": {
            "fieldsNotFound": [],
            "outputMessages": [],
            "phrasesIgnored": [],
            "translationSet": [],
            "phrasesNotFound": [],
            "queryTranslation": "\"diabetes mellitus, type 2\"[MeSH Terms]",
            "quotedPhrasesNotFound": []
          },
          "reportedCount": null
        },
        {
          "no": 2,
          "kind": "raw",
          "refs": [],
          "count": 10378,
          "query": "\"Glucagon-Like Peptide-1 Receptor Agonists\"[Mesh] OR semaglutide[tiab]",
          "issues": [],
          "display": "\"Glucagon-Like Peptide-1 Receptor Agonists\"[Mesh] OR semaglutide[tiab]",
          "countedAt": "2026-10-28T20:14:57.582Z",
          "vocabulary": [
            {
              "tag": "Mesh",
              "kind": "descriptor",
              "label": "Glucagon-Like Peptide-1 Receptor Agonists",
              "quoted": true,
              "validation": {
                "ui": "D000097789",
                "label": "Glucagon-Like Peptide-1 Receptor Agonists",
                "status": "valid"
              }
            }
          ],
          "diagnostics": {
            "fieldsNotFound": [],
            "outputMessages": [],
            "phrasesIgnored": [],
            "translationSet": [],
            "phrasesNotFound": [],
            "queryTranslation": "\"Glucagon-Like Peptide-1 Receptor Agonists\"[MeSH Terms] OR \"semaglutide\"[Title/Abstract]",
            "quotedPhrasesNotFound": []
          },
          "reportedCount": null
        },
        {
          "no": 3,
          "kind": "raw",
          "refs": [
            1,
            2
          ],
          "count": 4461,
          "query": "(\"Diabetes Mellitus, Type 2\"[Mesh]) AND (\"Glucagon-Like Peptide-1 Receptor Agonists\"[Mesh] OR semaglutide[tiab])",
          "issues": [],
          "display": "#1 AND #2",
          "countedAt": "2026-10-28T20:14:57.338Z",
          "diagnostics": {
            "fieldsNotFound": [],
            "outputMessages": [],
            "phrasesIgnored": [],
            "translationSet": [],
            "phrasesNotFound": [],
            "queryTranslation": "\"diabetes mellitus, type 2\"[MeSH Terms] AND (\"Glucagon-Like Peptide-1 Receptor Agonists\"[MeSH Terms] OR \"semaglutide\"[Title/Abstract])",
            "quotedPhrasesNotFound": []
          },
          "reportedCount": null
        }
      ],
      "finalQuery": "(\"Diabetes Mellitus, Type 2\"[Mesh]) AND (\"Glucagon-Like Peptide-1 Receptor Agonists\"[Mesh] OR semaglutide[tiab])",
      "finalCount": 4461,
      "createdAt": "2026-10-28T20:15:00.791Z"
    }
  ],
  "llmCalls": [],
  "events": [
    {
      "seq": 1,
      "event": {
        "type": "stage",
        "stage": "parsing",
        "message": "Reading the numbered search lines"
      }
    },
    {
      "seq": 2,
      "event": {
        "type": "lines",
        "lines": [
          {
            "no": 1,
            "kind": "raw",
            "refs": [],
            "count": null,
            "query": "\"Diabetes Mellitus, Type 2\"[Mesh]",
            "issues": [],
            "display": "\"Diabetes Mellitus, Type 2\"[Mesh]",
            "reportedCount": null
          },
          {
            "no": 2,
            "kind": "raw",
            "refs": [],
            "count": null,
            "query": "\"Glucagon-Like Peptide-1 Receptor Agonists\"[Mesh] OR semaglutide[tiab]",
            "issues": [],
            "display": "\"Glucagon-Like Peptide-1 Receptor Agonists\"[Mesh] OR semaglutide[tiab]",
            "reportedCount": null
          },
          {
            "no": 3,
            "kind": "raw",
            "refs": [
              1,
              2
            ],
            "count": null,
            "query": "(\"Diabetes Mellitus, Type 2\"[Mesh]) AND (\"Glucagon-Like Peptide-1 Receptor Agonists\"[Mesh] OR semaglutide[tiab])",
            "issues": [],
            "display": "#1 AND #2",
            "reportedCount": null
          }
        ]
      }
    },
    {
      "seq": 3,
      "event": {
        "type": "stage",
        "stage": "validating_vocabulary",
        "message": "Checking 2 vocabulary terms against NLM MeSH"
      }
    },
    {
      "seq": 4,
      "event": {
        "type": "lines",
        "lines": [
          {
            "no": 1,
            "kind": "raw",
            "refs": [],
            "count": null,
            "query": "\"Diabetes Mellitus, Type 2\"[Mesh]",
            "issues": [],
            "display": "\"Diabetes Mellitus, Type 2\"[Mesh]",
            "vocabulary": [
              {
                "tag": "Mesh",
                "kind": "descriptor",
                "label": "Diabetes Mellitus, Type 2",
                "quoted": true,
                "validation": {
                  "ui": "D003924",
                  "label": "Diabetes Mellitus, Type 2",
                  "status": "valid"
                }
              }
            ],
            "reportedCount": null
          },
          {
            "no": 2,
            "kind": "raw",
            "refs": [],
            "count": null,
            "query": "\"Glucagon-Like Peptide-1 Receptor Agonists\"[Mesh] OR semaglutide[tiab]",
            "issues": [],
            "display": "\"Glucagon-Like Peptide-1 Receptor Agonists\"[Mesh] OR semaglutide[tiab]",
            "vocabulary": [
              {
                "tag": "Mesh",
                "kind": "descriptor",
                "label": "Glucagon-Like Peptide-1 Receptor Agonists",
                "quoted": true,
                "validation": {
                  "ui": "D000097789",
                  "label": "Glucagon-Like Peptide-1 Receptor Agonists",
                  "status": "valid"
                }
              }
            ],
            "reportedCount": null
          },
          {
            "no": 3,
            "kind": "raw",
            "refs": [
              1,
              2
            ],
            "count": null,
            "query": "(\"Diabetes Mellitus, Type 2\"[Mesh]) AND (\"Glucagon-Like Peptide-1 Receptor Agonists\"[Mesh] OR semaglutide[tiab])",
            "issues": [],
            "display": "#1 AND #2",
            "reportedCount": null
          }
        ]
      }
    },
    {
      "seq": 5,
      "event": {
        "type": "stage",
        "stage": "counting",
        "message": "Running 3 lines on PubMed"
      }
    },
    {
      "seq": 6,
      "event": {
        "done": 1,
        "type": "progress",
        "total": 3,
        "message": "Line 1: 204,451 records"
      }
    },
    {
      "seq": 7,
      "event": {
        "done": 2,
        "type": "progress",
        "total": 3,
        "message": "Line 3: 4,461 records"
      }
    },
    {
      "seq": 8,
      "event": {
        "done": 3,
        "type": "progress",
        "total": 3,
        "message": "Line 2: 10,378 records"
      }
    },
    {
      "seq": 9,
      "event": {
        "type": "lines",
        "lines": [
          {
            "no": 1,
            "kind": "raw",
            "refs": [],
            "count": 204451,
            "query": "\"Diabetes Mellitus, Type 2\"[Mesh]",
            "issues": [],
            "display": "\"Diabetes Mellitus, Type 2\"[Mesh]",
            "countedAt": "2026-10-28T18:00:07.299Z",
            "vocabulary": [
              {
                "tag": "Mesh",
                "kind": "descriptor",
                "label": "Diabetes Mellitus, Type 2",
                "quoted": true,
                "validation": {
                  "ui": "D003924",
                  "label": "Diabetes Mellitus, Type 2",
                  "status": "valid"
                }
              }
            ],
            "diagnostics": {
              "fieldsNotFound": [],
              "outputMessages": [],
              "phrasesIgnored": [],
              "translationSet": [],
              "phrasesNotFound": [],
              "queryTranslation": "\"diabetes mellitus, type 2\"[MeSH Terms]",
              "quotedPhrasesNotFound": []
            },
            "reportedCount": null
          },
          {
            "no": 2,
            "kind": "raw",
            "refs": [],
            "count": 10378,
            "query": "\"Glucagon-Like Peptide-1 Receptor Agonists\"[Mesh] OR semaglutide[tiab]",
            "issues": [],
            "display": "\"Glucagon-Like Peptide-1 Receptor Agonists\"[Mesh] OR semaglutide[tiab]",
            "countedAt": "2026-10-28T20:14:57.582Z",
            "vocabulary": [
              {
                "tag": "Mesh",
                "kind": "descriptor",
                "label": "Glucagon-Like Peptide-1 Receptor Agonists",
                "quoted": true,
                "validation": {
                  "ui": "D000097789",
                  "label": "Glucagon-Like Peptide-1 Receptor Agonists",
                  "status": "valid"
                }
              }
            ],
            "diagnostics": {
              "fieldsNotFound": [],
              "outputMessages": [],
              "phrasesIgnored": [],
              "translationSet": [],
              "phrasesNotFound": [],
              "queryTranslation": "\"Glucagon-Like Peptide-1 Receptor Agonists\"[MeSH Terms] OR \"semaglutide\"[Title/Abstract]",
              "quotedPhrasesNotFound": []
            },
            "reportedCount": null
          },
          {
            "no": 3,
            "kind": "raw",
            "refs": [
              1,
              2
            ],
            "count": 4461,
            "query": "(\"Diabetes Mellitus, Type 2\"[Mesh]) AND (\"Glucagon-Like Peptide-1 Receptor Agonists\"[Mesh] OR semaglutide[tiab])",
            "issues": [],
            "display": "#1 AND #2",
            "countedAt": "2026-10-28T20:14:57.338Z",
            "diagnostics": {
              "fieldsNotFound": [],
              "outputMessages": [],
              "phrasesIgnored": [],
              "translationSet": [],
              "phrasesNotFound": [],
              "queryTranslation": "\"diabetes mellitus, type 2\"[MeSH Terms] AND (\"Glucagon-Like Peptide-1 Receptor Agonists\"[MeSH Terms] OR \"semaglutide\"[Title/Abstract])",
              "quotedPhrasesNotFound": []
            },
            "reportedCount": null
          }
        ]
      }
    },
    {
      "seq": 10,
      "event": {
        "type": "stage",
        "stage": "fetching_records",
        "message": "Fetching the first 20 records of line 3"
      }
    },
    {
      "seq": 11,
      "event": {
        "type": "records",
        "total": 4461,
        "records": [
          {
            "pmid": "42947001",
            "year": "2026",
            "title": "Comparison of cardiac adverse event signal profiles for GLP-1 receptor agonists: an analysis of the FAERS database.",
            "authors": "Yildirim BO, Sarkim IF, Yalman G et al.",
            "journal": "BMC cardiovascular disorders",
            "publicationTypes": [
              "Journal Article",
              "Comparative Study"
            ]
          },
          {
            "pmid": "42946127",
            "year": "2026",
            "title": "Semaglutide and Panic Attacks: Active-Comparator Disproportionality Analysis, Temporal Assessment of Notoriety Bias and Evidence Triangulation in Post-Marketing Pharmacovigilance.",
            "authors": "Melamed B, Parsi-Zahabi M, Omrani MA et al.",
            "journal": "Pharmacoepidemiology and drug safety",
            "publicationTypes": [
              "Journal Article"
            ]
          },
          {
            "pmid": "42944687",
            "year": "2026",
            "title": "GLP-1 RA Prescribing in Patients With Type 2 Diabetes and Cancer.",
            "authors": "Hu X, Jiang C, Han X et al.",
            "journal": "JAMA network open",
            "publicationTypes": [
              "Journal Article"
            ]
          },
          {
            "pmid": "42944684",
            "year": "2026",
            "title": "Prescribing SGLTis and GLP-1 RAs for Patients With Type 2 Diabetes, Guideline Updates, and Longitudinal Knowledge Assessment Scores.",
            "authors": "Gray BM, Vandergrift J, Landon BE et al.",
            "journal": "JAMA network open",
            "publicationTypes": [
              "Journal Article"
            ]
          },
          {
            "pmid": "42942883",
            "year": "2026",
            "title": "Impact of GLP-1 Receptor Agonists on Cognitive Performance in Adults at Risk of Alzheimer's Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.",
            "authors": "Abbatecola AM, Migliara G, D'Agostino F et al.",
            "journal": "Nutrients",
            "publicationTypes": [
              "Journal Article",
              "Systematic Review",
              "Meta-Analysis",
              "Review"
            ]
          },
          {
            "pmid": "42942021",
            "year": "2026",
            "title": "GLP-1 Receptor Agonist Therapy in Patients with Cancer: A Review of Clinical Outcomes.",
            "authors": "Andronescu AC, Ciumărnean L, Orășan OH et al.",
            "journal": "International journal of molecular sciences",
            "publicationTypes": [
              "Journal Article",
              "Systematic Review",
              "Review"
            ]
          },
          {
            "pmid": "42941904",
            "year": "2026",
            "title": "Association of Glucagon-like Peptide-1 Receptor Agonists Versus Dipeptidyl Peptidase-4 Inhibitors with Tuberculosis and Mortality in Adults with Diabetes.",
            "authors": "Hsu CH, Chang R, Chen CF et al.",
            "journal": "International journal of molecular sciences",
            "publicationTypes": [
              "Journal Article",
              "Observational Study"
            ]
          },
          {
            "pmid": "42937793",
            "year": "2026",
            "title": "Efficacy and safety of GLP-1 receptor agonists in patients with metabolic dysfunction-associated steatotic liver disease (MASLD) and metabolic dysfunction-associated steatohepatitis (MASH): A systematic review and meta-analysis.",
            "authors": "Alfawaz M, Bajamaan D, Alghamdi L et al.",
            "journal": "Medicine",
            "publicationTypes": [
              "Journal Article",
              "Systematic Review",
              "Meta-Analysis"
            ]
          },
          {
            "pmid": "42918905",
            "year": "2026",
            "title": "GLP-1-based therapies in cardiovascular disease: outcomes, mechanisms, and emerging clinical applications.",
            "authors": "Jang R, Jang M, Ruan X et al.",
            "journal": "European journal of clinical pharmacology",
            "publicationTypes": [
              "Journal Article",
              "Review"
            ]
          },
          {
            "pmid": "42916694",
            "year": "2026",
            "title": "Oral Small-Molecule GLP-1 Receptor Agonists: Lessons from Clinical Candidates and a Blueprint for Next-Generation Design.",
            "authors": "Hu J, Zhang Y, Wang M et al.",
            "journal": "Journal of medicinal chemistry",
            "publicationTypes": [
              "Journal Article"
            ]
          },
          {
            "pmid": "42910111",
            "year": "2026",
            "title": "Association of GLP-1 Receptor Agonist Use with Thyroid Outcomes in Adults with Type 2 Diabetes.",
            "authors": "Hsiao CC, Tsai MH, Jhu JY et al.",
            "journal": "International journal of medical sciences",
            "publicationTypes": [
              "Journal Article"
            ]
          },
          {
            "pmid": "42905300",
            "year": "2026",
            "title": "Decoding the Safety Profile of GLP-1 Receptor Agonists: Facts, Myths, and Ongoing Controversies.",
            "authors": "Kounatidis DC, Vallianou NG, Kouveletsou M et al.",
            "journal": "Current obesity reports",
            "publicationTypes": [
              "Journal Article",
              "Review"
            ]
          },
          {
            "pmid": "42902671",
            "year": "2026",
            "title": "Real-world Challenges and Predictors of Success in Glucagon-like Peptide-1 Receptor Agonist Therapy.",
            "authors": "Patankar NM, Sanghvi SJ",
            "journal": "The Journal of the Association of Physicians of India",
            "publicationTypes": [
              "Journal Article",
              "Review"
            ]
          },
          {
            "pmid": "42899606",
            "year": "2026",
            "title": "Effectiveness of Weekly Semaglutide Treatment (0.5 or 1 mg) in Chilean Patients with Type 2 Diabetes Mellitus.",
            "authors": "Estica M, Godoy G, Vargas C et al.",
            "journal": "Revista medica de Chile",
            "publicationTypes": [
              "Journal Article",
              "Multicenter Study",
              "Clinical Trial, Phase IV"
            ]
          },
          {
            "pmid": "42898660",
            "year": "2026",
            "title": "Glucagon-like peptide-1 receptor agonists and aesthetic surgery: perioperative safety, timing, durability and body composition.",
            "authors": "Chaturvedi R, Singh K, Chakole RR et al.",
            "journal": "Frontiers in endocrinology",
            "publicationTypes": [
              "Journal Article",
              "Review"
            ]
          },
          {
            "pmid": "42890523",
            "year": "2026",
            "title": "CagriSema versus Semaglutide 2.4 mg monotherapy for weight management in adults with overweight or obesity, with or without type 2 diabetes: a systematic review, meta-analysis, and trial sequential analysis.",
            "authors": "Rasool ZK, Shah R, Batool AEZ et al.",
            "journal": "Frontiers in endocrinology",
            "publicationTypes": [
              "Journal Article",
              "Systematic Review",
              "Meta-Analysis"
            ]
          },
          {
            "pmid": "42886550",
            "year": "2026",
            "title": "Pharmacy students' knowledge and attitudes regarding GLP-1 receptor agonist adverse effects in obesity management: a cross-sectional study.",
            "authors": "Khojah AA, Gazzaz MJ, Aldurdunji MM et al.",
            "journal": "The Libyan journal of medicine",
            "publicationTypes": [
              "Journal Article"
            ]
          },
          {
            "pmid": "42885796",
            "year": "2026",
            "title": "Glucagon-Like Peptide-1 Receptor Agonists and Incident Cardiovascular Events and Death in Treated Serious Mental Illness, Type 2 Diabetes, and Obesity.",
            "authors": "Governor SB, Dávila-García DM, Rivera-Segarra E et al.",
            "journal": "Journal of the American Heart Association",
            "publicationTypes": [
              "Journal Article"
            ]
          },
          {
            "pmid": "42874603",
            "year": "2026",
            "title": "GLP-1 receptor agonist initiation and risk of psychiatric hospitalisation and emergency department presentation in adults with schizophrenia and type 2 diabetes in the USA: an observational cohort study using electronic health records data.",
            "authors": "Davoodian N, Williams LJ, Berk M et al.",
            "journal": "The lancet. Psychiatry",
            "publicationTypes": [
              "Journal Article",
              "Observational Study"
            ]
          },
          {
            "pmid": "42866418",
            "year": "2026",
            "title": "Values, preferences, and treatment burden for initiation of GLP-1 receptor agonists, SGLT-2 inhibitors, tirzepatide, and finerenone in adults with type 2 diabetes: systematic review.",
            "authors": "González-Cruz DC, Garcia-Campa M, Moreno-Peña PJ et al.",
            "journal": "BMJ medicine",
            "publicationTypes": [
              "Journal Article",
              "Systematic Review"
            ]
          }
        ]
      }
    },
    {
      "seq": 12,
      "event": {
        "type": "stage",
        "stage": "saving",
        "message": "Saving the run"
      }
    },
    {
      "seq": 13,
      "event": {
        "type": "done",
        "finalCount": 4461
      }
    }
  ]
}